Stereoselectivity of the 4‐hydroxylation of debrisoquine in man, detected by gas chromatography/mass spectrometry 1 | Zendy

Meese C. O. | Zendy; Fischer C. | Zendy; Eichelbaum M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Stereoselectivity of the 4‐hydroxylation of debrisoquine in man, detected by gas chromatography/mass spectrometry 1

Author(s) -

Meese C. O.,

Fischer C.,

Eichelbaum M.

Publication year - 1988

Publication title -

biomedical and environmental mass spectrometry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 121

eISSN - 1096-9888

pISSN - 0887-6134

DOI - 10.1002/bms.1200150202

Subject(s) - debrisoquine , hydroxylation , stereoselectivity , gas chromatography , chromatography , chemistry , gas chromatography–mass spectrometry , mass spectrometry , organic chemistry , biochemistry , metabolism , cyp2d6 , catalysis , cytochrome p450 , enzyme

A stable isotope assay for the quantification of debrisoquine (1) and its major urinary metabolite 4‐hydroxydebrisoquine (2) is described. The method consists of extractive derivatization of 1 and 2 by use of 1,3‐diketones, chiral derivatization of the 4‐hydroxy group of 2, and gas chromatography/negative ion chemical ionization mass spectrometry in the presence of deuterated analogues of 1 and 2. In comparison with synthetic R ‐(−)‐2 and S ‐(+)−2 it is shown that in vivo benzylic 4‐hydroxylation of 1 is highly stereoselective, leading predominantly to S ‐(+)‐4‐hydroxydebrisoquine (enantiomeric excess ⩾90%).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research